Gimv logo

Gimv

Europe, Antwerpen, Belgium, Antwerpen

Description

Gimv is a prominent European private equity and venture capital firm with a rich history spanning over four decades, having been established in 1980. Listed on Euronext Brussels, the firm has cultivated a reputation as a long-term, active investor focused on fostering growth in established companies across various sectors. With approximately €1.6 billion in assets under management as of September 30, 2023, Gimv invests both from its own balance sheet and through third-party funds, demonstrating a robust and flexible capital base. Its strategic approach emphasizes building strong partnerships with management teams to drive sustainable value creation.

The firm's investment strategy is structured around four distinct platforms: Connected Consumer, which targets consumer goods, retail, and digital consumer services; Health & Care, focusing on medtech, digital health, and care services; Smart Industries, encompassing advanced manufacturing, industrial services, and cleantech; and Sustainable Cities, which includes infrastructure, real estate, and energy transition initiatives. This platform-based approach allows Gimv to leverage deep sector expertise and a broad network to identify and support high-potential companies. They typically seek out growth-oriented businesses with enterprise values ranging from €20 million to €500 million, indicating a focus on the lower-mid to mid-market segments.

Gimv primarily targets companies located in the Benelux region, France, and Germany, while also increasingly exploring opportunities across the broader European landscape. The firm's typical equity investment per transaction ranges from €10 million to €50 million, providing significant growth capital for expansion, internationalization, and strategic acquisitions. Their commitment extends beyond mere capital provision, offering strategic guidance and operational support to help portfolio companies achieve their full potential. This comprehensive approach underscores Gimv's dedication to being a true partner in growth, contributing to the long-term success of the businesses they back.

Investor Profile

Gimv has backed more than 189 startups, with 3 new investments in the last 12 months alone. The firm has led 61 rounds, about 32% of its total and boasts 60 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series Unknown, Series A rounds (top funding stages).
  • Majority of deals are located in United States, Belgium, France.
  • Strong thematic focus on Biotechnology, Health Care, Medical.
  • Typical check size: $10.8M – $54M.

Stage Focus

  • Series B (23%)
  • Series Unknown (21%)
  • Series A (16%)
  • Series C (15%)
  • Private Equity (14%)
  • Series D (6%)
  • Series E (2%)
  • Series F (1%)
  • Seed (1%)
  • Post Ipo Equity (1%)

Country Focus

  • United States (24%)
  • Belgium (23%)
  • France (15%)
  • The Netherlands (13%)
  • United Kingdom (7%)
  • Germany (6%)
  • Switzerland (5%)
  • Ireland (2%)
  • Israel (1%)
  • Canada (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Software
  • Therapeutics
  • Manufacturing
  • Medical Device
  • Pharmaceutical
  • Biopharma
  • Information Technology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Gimv frequently co-invest with?

3i Group
Europe, England, United Kingdom, London
Co-Investments: 10
VI Partners
Europe, Schwyz, Switzerland, Altendorf
Co-Investments: 8
Atlas Venture
North America, Massachusetts, United States, Cambridge
Co-Investments: 8
Andera Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 13
Neomed Management
Europe, Oslo, Norway, Oslo
Co-Investments: 10
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 16
EQT Life Sciences
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 17
Sofinnova Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 16
Forward Ventures
North America, California, United States, San Diego
Co-Investments: 8
Gilde Healthcare
Europe, Utrecht, The Netherlands, Utrecht
Co-Investments: 9

Which angels does Gimv often collaborate with?

FC
North America, Florida, United States, Boca Raton
Shared Deals: 1
LF
Europe, Vaud, Switzerland, Lausanne
Shared Deals: 1
Dave Marver
North America, Washington, United States, Seattle
Shared Deals: 1
JB
Europe, Vaud, Switzerland, Lausanne
Shared Deals: 1
Shared Deals: 1
PC
Europe, Geneve, Switzerland, Geneva
Shared Deals: 1
JM
North America, Massachusetts, United States, Boston
Shared Deals: 1
GC
Europe, Vaud, Switzerland, Lausanne
Shared Deals: 1
RO
North America, Iowa, United States, Des Moines
Shared Deals: 1
KD
Europe, Vaud, Switzerland
Shared Deals: 1

What are some of recent deals done by Gimv?

FIRE1

Dublin, Dublin, Ireland

FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.

BiotechnologyHealth CareMedical DeviceTherapeutics
Series UnknownJan 7, 2025
Amount Raised: $120,000,000
Kivu Bioscience

San Francisco, California, United States

Kivu Bioscience is a biotechnology company that focuses on developing next-generation antibody-drug conjugates to target cancer.

BiotechnologyHealth CareOncology
Series AOct 28, 2024
Amount Raised: $92,000,000
ImmunOs Therapeutics

Schlieren, Zurich, Switzerland

ImmunOs Therapeutics is a clinical-stage biotechnology company.

BiotechnologyHealth CarePharmaceutical
Series CSep 17, 2024
Amount Raised: $11,000,000
Curana

Ardooie, West-Vlaanderen, Belgium

Curana is a manufacturer of bike equipment and accessories.

AutomotiveManufacturingProduct Design
Private EquityJul 2, 2024
Onward

Eindhoven, Noord-Brabant, The Netherlands

Onward develops an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools.

BiotechnologyHealth CareMachinery ManufacturingMedicalMedical DeviceTherapeutics
Post Ipo EquityMar 20, 2024
Amount Raised: $21,875,113
Onera Health

Eindhoven, Noord-Brabant, The Netherlands

Onera Health is a global leader in sleep diagnostics and monitoring.

Health CareHealth DiagnosticsMedicalMedical DeviceNanotechnologyWearables
Series CJan 16, 2024
Amount Raised: $32,635,691
ERS

Munich, Bayern, Germany

ERS is a semiconductor manufacturing company that offers thermal wafer testing and Air-Cool technology services.

Industrial ManufacturingInformation TechnologyManufacturingSemiconductor
Private EquityJun 1, 2023
Complement Therapeutics

London, England, United Kingdom

Complement Therapeutics operates as a preclinical stage company.

BiotechnologyMedical
Series AApr 17, 2023
Amount Raised: $78,657,148
Mediar Therapeutics

Cambridge, Massachusetts, United States

Mediar is a pre-clinical stage biotechnology company developing therapeutics for the treatment of fibrosis.

BiotechnologyHealth CareMedicalTherapeutics
Series AMar 15, 2023
Amount Raised: $85,000,000
FIRE1

Dublin, Dublin, Ireland

FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.

BiotechnologyHealth CareMedical DeviceTherapeutics
Series UnknownMar 15, 2023
Amount Raised: $25,000,000